Favipiravir for the prevention and management of COVID‐19: evidence review of the clinical benefit and harm

Simple item page
dc.contributor.authorBlockman, M.
dc.contributor.authorCohen, K. 
dc.contributor.authorDe Waal, R.
dc.contributor.authorGray, A.
dc.contributor.authorKredo, T.
dc.contributor.authorMaartens, G.
dc.contributor.authorNel, J.
dc.contributor.authorParrish, A.
dc.contributor.authorRees, H.
dc.contributor.authorReubenson, G.
dc.contributor.departmentCochrane South Africa, South  African Medical Research Councilen_US
dc.date.accessioned2020-07-20T09:04:36Z
dc.date.available2020-07-20T09:04:36Z
dc.date.epub2020-06-25
dc.date.issued2020-06-25
dc.identifier.urihttps://infospace.mrc.ac.za/handle/11288/595267
dc.language.isoenen_US
dc.publisherSouth African National Department of Healthen_US
dc.research.unitSouth African Cochrane Centreen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleFavipiravir for the prevention and management of COVID‐19: evidence review of the clinical benefit and harmen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Blockman M-2020_Favipiravir for.pdf
Size:
230.63 KB
Format:
Adobe Portable Document Format
Description:
Thumbnail Image
Name: Blockman M-2020_Favipiravir for.pdf
Size: 230.63 KB
Kind: Adobe PDF
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Name: license.txt
Size: 1.71 KB
Kind: License
Collections
Intramural: Journal Articles